Literature DB >> 8713674

Sodium status, corticosteroid metabolism and blood pressure in normal human subjects and in a patient with abnormal salt appetite.

M C Ingram1, A M Wallace, A Collier, R Fraser, J M Connell.   

Abstract

1. A patient with severe hypertension was found to have mildly impaired 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) activity on the basis of urinary steroid metabolite ratios, low plasma aldosterone, angiotensin II and renin levels and marginally low levels of plasma potassium. 2. The patient also had a compulsively high salt intake. 3. We tested the hypothesis that high salt intake may affect 11 beta-HSD activity. 4. High salt intake in normal subjects did not significantly alter either blood pressure or 11 beta-HSD activity. 5. We suggest that the potentially small hypertensive effect of the partial enzyme deficiency in our patient, also reported in patients with essential hypertension, has been markedly amplified by the very high salt intake.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8713674     DOI: 10.1111/j.1440-1681.1996.tb02744.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

Review 1.  Aldosterone-related genetic effects in hypertension.

Authors:  D G Warnock
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 2.  Aldosterone in the brain.

Authors:  Joel C Geerling; Arthur D Loewy
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-04

Review 3.  The epithelial sodium channel in hypertension.

Authors:  D G Warnock
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 4.  Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms.

Authors:  Yiling Fu; Volker Vallon
Journal:  Nephron Physiol       Date:  2014-11-06

5.  11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension.

Authors:  Carmen Campino; Cristian A Carvajal; Javiera Cornejo; Betty San Martín; Oliviero Olivieri; Giancesare Guidi; Giovanni Faccini; Francesco Pasini; Javiera Sateler; Rene Baudrand; Lorena Mosso; Gareth I Owen; Alexis M Kalergis; Oslando Padilla; Carlos E Fardella
Journal:  Endocrine       Date:  2009-10-31       Impact factor: 3.633

6.  11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension.

Authors:  Lama Ghazi; Tanja Dudenbostel; Maria El Hachem; Mohammed Siddiqui; Chee Paul Lin; Suzanne Oparil; David A Calhoun
Journal:  Am J Hypertens       Date:  2017-05-01       Impact factor: 2.689

7.  ISN Forefronts Symposium 2015: The Evolution of Hypertension-Old Genes, New Concepts.

Authors:  Morag K Mansley; Jessica R Ivy; Matthew A Bailey
Journal:  Kidney Int Rep       Date:  2016-09

8.  Conditional Deletion of Hsd11b2 in the Brain Causes Salt Appetite and Hypertension.

Authors:  Louise C Evans; Jessica R Ivy; Caitlin Wyrwoll; Julie A McNairn; Robert I Menzies; Thorbjørn H Christensen; Emad A S Al-Dujaili; Christopher J Kenyon; John J Mullins; Jonathan R Seckl; Megan C Holmes; Matthew A Bailey
Journal:  Circulation       Date:  2016-03-07       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.